vs
Side-by-side financial comparison of NORTECH SYSTEMS INC (NSYS) and ORASURE TECHNOLOGIES INC (OSUR). Click either name above to swap in a different company.
NORTECH SYSTEMS INC is the larger business by last-quarter revenue ($30.3M vs $26.8M, roughly 1.1× ORASURE TECHNOLOGIES INC). NORTECH SYSTEMS INC runs the higher net margin — 3.0% vs -72.1%, a 75.0% gap on every dollar of revenue. On growth, NORTECH SYSTEMS INC posted the faster year-over-year revenue change (5.9% vs -28.5%). NORTECH SYSTEMS INC produced more free cash flow last quarter ($5.5M vs $-9.9M). Over the past eight quarters, NORTECH SYSTEMS INC's revenue compounded faster (-5.9% CAGR vs -29.7%).
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
NSYS vs OSUR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.3M | $26.8M |
| Net Profit | $897.0K | $-19.3M |
| Gross Margin | 16.7% | 41.0% |
| Operating Margin | 3.0% | -75.1% |
| Net Margin | 3.0% | -72.1% |
| Revenue YoY | 5.9% | -28.5% |
| Net Profit YoY | 160.7% | -78.7% |
| EPS (diluted) | $0.32 | $-0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.3M | $26.8M | ||
| Q3 25 | $30.5M | $27.1M | ||
| Q2 25 | $30.7M | $31.2M | ||
| Q1 25 | $26.9M | $29.9M | ||
| Q4 24 | $28.6M | $37.4M | ||
| Q3 24 | $31.4M | $39.9M | ||
| Q2 24 | $33.9M | $54.3M | ||
| Q1 24 | $34.2M | $54.1M |
| Q4 25 | $897.0K | $-19.3M | ||
| Q3 25 | $-146.0K | $-13.7M | ||
| Q2 25 | $313.0K | $-19.7M | ||
| Q1 25 | $-1.3M | $-16.0M | ||
| Q4 24 | $-1.5M | $-10.8M | ||
| Q3 24 | $-739.0K | $-4.5M | ||
| Q2 24 | $157.0K | $-615.0K | ||
| Q1 24 | $765.0K | $-3.6M |
| Q4 25 | 16.7% | 41.0% | ||
| Q3 25 | 16.5% | 43.5% | ||
| Q2 25 | 15.8% | 42.1% | ||
| Q1 25 | 11.4% | 41.1% | ||
| Q4 24 | 9.9% | 36.2% | ||
| Q3 24 | 12.2% | 42.8% | ||
| Q2 24 | 13.6% | 45.4% | ||
| Q1 24 | 15.9% | 44.5% |
| Q4 25 | 3.0% | -75.1% | ||
| Q3 25 | 3.1% | -59.4% | ||
| Q2 25 | 2.4% | -57.7% | ||
| Q1 25 | -6.0% | -59.3% | ||
| Q4 24 | -4.3% | -33.2% | ||
| Q3 24 | -1.5% | -15.0% | ||
| Q2 24 | 1.0% | -5.0% | ||
| Q1 24 | 3.4% | -13.1% |
| Q4 25 | 3.0% | -72.1% | ||
| Q3 25 | -0.5% | -50.6% | ||
| Q2 25 | 1.0% | -63.0% | ||
| Q1 25 | -4.9% | -53.6% | ||
| Q4 24 | -5.2% | -28.8% | ||
| Q3 24 | -2.4% | -11.3% | ||
| Q2 24 | 0.5% | -1.1% | ||
| Q1 24 | 2.2% | -6.6% |
| Q4 25 | $0.32 | $-0.28 | ||
| Q3 25 | $-0.05 | $-0.19 | ||
| Q2 25 | $0.12 | $-0.26 | ||
| Q1 25 | $-0.48 | $-0.21 | ||
| Q4 24 | $-0.51 | $-0.14 | ||
| Q3 24 | $-0.27 | $-0.06 | ||
| Q2 24 | $0.05 | $-0.01 | ||
| Q1 24 | $0.26 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $199.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $34.5M | $340.8M |
| Total Assets | $71.9M | $403.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $199.3M | ||
| Q3 25 | $1.3M | $216.5M | ||
| Q2 25 | $652.0K | $234.6M | ||
| Q1 25 | $1.2M | $247.6M | ||
| Q4 24 | $916.0K | $267.8M | ||
| Q3 24 | $1.2M | $278.6M | ||
| Q2 24 | $1.5M | $267.4M | ||
| Q1 24 | $4.0M | $263.8M |
| Q4 25 | $34.5M | $340.8M | ||
| Q3 25 | $33.4M | $362.0M | ||
| Q2 25 | $33.4M | $380.7M | ||
| Q1 25 | $32.8M | $396.3M | ||
| Q4 24 | $34.0M | $410.3M | ||
| Q3 24 | $35.7M | $425.6M | ||
| Q2 24 | $36.1M | $425.8M | ||
| Q1 24 | $36.0M | $426.3M |
| Q4 25 | $71.9M | $403.2M | ||
| Q3 25 | $74.8M | $423.1M | ||
| Q2 25 | $74.8M | $445.0M | ||
| Q1 25 | $73.5M | $457.6M | ||
| Q4 24 | $72.4M | $479.7M | ||
| Q3 24 | $77.0M | $464.1M | ||
| Q2 24 | $76.3M | $466.3M | ||
| Q1 24 | $75.5M | $467.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.6M | $-9.0M |
| Free Cash FlowOCF − Capex | $5.5M | $-9.9M |
| FCF MarginFCF / Revenue | 18.0% | -37.1% |
| Capex IntensityCapex / Revenue | 0.5% | 3.4% |
| Cash ConversionOCF / Net Profit | 6.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-53.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $-9.0M | ||
| Q3 25 | $-92.0K | $-10.1M | ||
| Q2 25 | $157.0K | $-10.2M | ||
| Q1 25 | $-2.9M | $-19.7M | ||
| Q4 24 | $793.0K | $109.0K | ||
| Q3 24 | $-1.6M | $12.7M | ||
| Q2 24 | $-4.3M | $7.8M | ||
| Q1 24 | $2.8M | $6.7M |
| Q4 25 | $5.5M | $-9.9M | ||
| Q3 25 | $-242.0K | $-11.0M | ||
| Q2 25 | $58.0K | $-12.2M | ||
| Q1 25 | $-3.2M | $-20.2M | ||
| Q4 24 | $503.0K | $-347.0K | ||
| Q3 24 | $-1.6M | $12.5M | ||
| Q2 24 | $-4.6M | $6.2M | ||
| Q1 24 | $2.1M | $5.2M |
| Q4 25 | 18.0% | -37.1% | ||
| Q3 25 | -0.8% | -40.6% | ||
| Q2 25 | 0.2% | -38.9% | ||
| Q1 25 | -11.9% | -67.3% | ||
| Q4 24 | 1.8% | -0.9% | ||
| Q3 24 | -5.2% | 31.4% | ||
| Q2 24 | -13.5% | 11.5% | ||
| Q1 24 | 6.1% | 9.5% |
| Q4 25 | 0.5% | 3.4% | ||
| Q3 25 | 0.5% | 3.4% | ||
| Q2 25 | 0.3% | 6.2% | ||
| Q1 25 | 1.0% | 1.4% | ||
| Q4 24 | 1.0% | 1.2% | ||
| Q3 24 | 0.1% | 0.4% | ||
| Q2 24 | 0.8% | 3.0% | ||
| Q1 24 | 2.2% | 2.9% |
| Q4 25 | 6.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -27.30× | — | ||
| Q1 24 | 3.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
OSUR
| Product And Services | $24.9M | 93% |
| Other | $1.9M | 7% |
